Agilent Technologies, Inc. (NYSE:A) Stock Holdings Decreased by TD Asset Management Inc.

TD Asset Management Inc. lessened its position in Agilent Technologies, Inc. (NYSE:A) by 7.0% in the 4th quarter, Holdings Channel reports. The fund owned 1,359,754 shares of the medical research company’s stock after selling 102,522 shares during the period. TD Asset Management Inc.’s holdings in Agilent Technologies were worth $182,669,000 at the end of the most recent quarter.

Other hedge funds also recently modified their holdings of the company. Modern Wealth Management LLC purchased a new stake in shares of Agilent Technologies in the fourth quarter worth approximately $288,000. Congress Wealth Management LLC DE lifted its position in Agilent Technologies by 58.0% in the 4th quarter. Congress Wealth Management LLC DE now owns 2,887 shares of the medical research company’s stock worth $388,000 after buying an additional 1,060 shares in the last quarter. LPL Financial LLC grew its holdings in shares of Agilent Technologies by 0.7% during the 4th quarter. LPL Financial LLC now owns 116,679 shares of the medical research company’s stock valued at $15,675,000 after acquiring an additional 793 shares in the last quarter. Fox Run Management L.L.C. purchased a new position in shares of Agilent Technologies during the 4th quarter valued at $470,000. Finally, KLP Kapitalforvaltning AS purchased a new stake in shares of Agilent Technologies during the fourth quarter worth $13,569,000.

Analyst Upgrades and Downgrades

A number of research analysts have commented on A shares. Sanford C. Bernstein lowered their target price on Agilent Technologies from $140.00 to $135.00 and set a “market perform” rating on the stock in a research note on Tuesday, November 26th. Wells Fargo & Company lowered their price target on Agilent Technologies from $157.00 to $155.00 and set an “overweight” rating for the company in a research note on Monday, December 9th. Barclays raised shares of Agilent Technologies from an “underweight” rating to an “equal weight” rating and raised their price objective for the company from $135.00 to $145.00 in a research report on Monday, February 10th. StockNews.com raised shares of Agilent Technologies from a “hold” rating to a “buy” rating in a research report on Tuesday, December 24th. Finally, JPMorgan Chase & Co. cut their price target on shares of Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating on the stock in a report on Tuesday, November 26th. Seven investment analysts have rated the stock with a hold rating and eight have given a buy rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $146.15.

Insider Activity

In related news, CEO Padraig Mcdonnell sold 1,911 shares of the company’s stock in a transaction on Tuesday, January 21st. The stock was sold at an average price of $150.00, for a total value of $286,650.00. Following the completion of the transaction, the chief executive officer now directly owns 39,652 shares in the company, valued at approximately $5,947,800. This represents a 4.60 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, VP Rodney Gonsalves sold 1,908 shares of Agilent Technologies stock in a transaction on Monday, March 17th. The stock was sold at an average price of $121.98, for a total transaction of $232,737.84. Following the sale, the vice president now owns 21,786 shares in the company, valued at $2,657,456.28. This represents a 8.05 % decrease in their position. The disclosure for this sale can be found here.

Agilent Technologies Price Performance

NYSE A opened at $120.35 on Wednesday. The stock has a 50-day simple moving average of $135.88 and a 200 day simple moving average of $137.05. Agilent Technologies, Inc. has a twelve month low of $117.17 and a twelve month high of $155.35. The stock has a market capitalization of $34.31 billion, a PE ratio of 27.67, a P/E/G ratio of 3.42 and a beta of 1.11. The company has a debt-to-equity ratio of 0.56, a quick ratio of 1.66 and a current ratio of 2.20.

Agilent Technologies (NYSE:A) last issued its quarterly earnings results on Wednesday, February 26th. The medical research company reported $1.31 EPS for the quarter, topping analysts’ consensus estimates of $1.27 by $0.04. Agilent Technologies had a return on equity of 25.56% and a net margin of 19.27%. The company had revenue of $1.68 billion during the quarter, compared to analyst estimates of $1.67 billion. Research analysts anticipate that Agilent Technologies, Inc. will post 5.57 EPS for the current year.

Agilent Technologies Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 23rd. Stockholders of record on Tuesday, April 1st will be issued a dividend of $0.248 per share. The ex-dividend date of this dividend is Tuesday, April 1st. This represents a $0.99 annualized dividend and a dividend yield of 0.82%. Agilent Technologies’s payout ratio is 22.76%.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.